Palisade Bio, Inc.
PALI
$2.14
-$0.01-0.47%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 500.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 500.00K | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 500.00K | -- | -- | -- | -- |
| SG&A Expenses | 4.80M | 4.35M | 3.81M | 1.53M | 1.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.20M | 10.75M | 9.98M | 2.92M | 2.84M |
| Operating Income | -11.70M | -10.75M | -9.98M | -2.92M | -2.84M |
| Income Before Tax | -10.57M | -9.60M | -8.90M | -2.87M | -2.78M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.57M | -9.60M | -8.90M | -2.87M | -2.78M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.57M | -9.60M | -8.90M | -2.87M | -2.78M |
| EBIT | -11.70M | -10.75M | -9.98M | -2.92M | -2.84M |
| EBITDA | -11.70M | -10.75M | -9.98M | -2.92M | -2.84M |
| EPS Basic | -0.05 | -0.05 | -0.04 | -0.38 | -0.58 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.24 | -0.36 |
| EPS Diluted | -0.05 | -0.05 | -0.04 | -0.38 | -0.58 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.24 | -0.36 |
| Average Basic Shares Outstanding | 211.38M | 209.66M | 205.57M | 7.47M | 4.80M |
| Average Diluted Shares Outstanding | 211.38M | 209.66M | 205.57M | 7.47M | 4.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |